​

Minerva Neurosciences (NERV) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

NERV Stock Forecast

Minerva Neurosciences (NERV) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a -36.22% decline from the last price of $7.84.

$2 $3 $4 $5 $6 $7 $8 High: $5 Avg: $5 Low: $5 Last Closed Price: $7.84

NERV Stock Rating

Minerva Neurosciences stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 2 Hold (28.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 2 5 Strong Sell Sell Hold Buy Strong Buy

NERV Price Target Upside V Benchmarks

TypeNameUpside
StockMinerva Neurosciences-36.22%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$5.00
Last Closing Price$7.84$7.84$7.84
Upside/Downside---36.22%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26--2--2
Feb, 26--2--2
Jan, 26--2--2
Dec, 25--2--2
Nov, 25--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 01, 2025Jefferies$5.00$3.8031.58%-36.22%
Aug 07, 2024Douglas TsaoH.C. Wainwright$5.00$2.9470.07%-36.22%
May 02, 2024Douglas TsaoH.C. Wainwright$7.00$2.40191.67%-10.71%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 12, 2026H.C. WainwrightNeutralNeutralhold
Dec 01, 2025JefferiesHoldHoldhold
Aug 07, 2024H.C. WainwrightNeutralNeutralhold
May 02, 2024H.C. WainwrightNeutralNeutralhold

Financial Forecast

EPS Forecast

$-35 $-27 $-19 $-11 $-3 $5 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-9.35$-4.61$0.19$-34.67---
Avg Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
High Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
Low Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
Surprise %37.30%8.22%-163.33%1193.66%---

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
High Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
Low Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
Surprise %-------

Net Income Forecast

$-300M $-230M $-160M $-90M $-20M $50M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.91M$-30.01M$1.44M$-293.42M---
Avg Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
High Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
Low Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
Surprise %12.59%8.26%-173.72%1582.75%---

NERV Forecast FAQ

Is Minerva Neurosciences stock a buy?

Minerva Neurosciences stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Minerva Neurosciences is a favorable investment for most analysts.

What is Minerva Neurosciences's price target?

Minerva Neurosciences's price target, set by 7 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential -36.22% change from the previous closing price of $7.84.

How does Minerva Neurosciences stock forecast compare to its benchmarks?

Minerva Neurosciences's stock forecast shows a -36.22% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Minerva Neurosciences over the past three months?

  • March 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Minerva Neurosciences’s EPS forecast?

Minerva Neurosciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.88, marking a -94.58% decrease from the reported $-34.67 in 2025. Estimates for the following years are $1.42 in 2027, and $1.62 in 2028.

What is Minerva Neurosciences’s revenue forecast?

Minerva Neurosciences's average annual revenue forecast for its fiscal year ending in December 2026 is $19.76M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $56.49M, and $137.88M for 2028.

What is Minerva Neurosciences’s net income forecast?

Minerva Neurosciences's net income forecast for the fiscal year ending in December 2026 stands at $-12.232M, representing a -95.83% decrease from the reported $-293M in 2025. Projections indicate $9.24M in 2027, and $10.54M in 2028.